These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 2019617)

  • 1. In vivo heparin response and consumption in patients before and during arterial reconstructive surgery.
    Stelmach WS; Myers KA; Scott DF; Devine TJ; Lee L
    J Cardiovasc Surg (Torino); 1991; 32(2):166-73. PubMed ID: 2019617
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intraoperative anticoagulation in cardiovascular surgery.
    Effeney DJ; Goldstone J; Chin D; Krupski WC; Ellis RJ
    Surgery; 1981 Dec; 90(6):1068-74. PubMed ID: 7313941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activated clotting time monitoring of intraoperative heparinization: our experience and comparison of two techniques.
    Mabry CD; Thompson BW; Read RC; Campbell GS
    Surgery; 1981 Nov; 90(5):889-95. PubMed ID: 7302842
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heparin neutralising activity of whole blood in patients undergoing vascular surgery.
    Harbourne T; Nicolaides AN; Golcman L; Shiffrin E
    J Cardiovasc Surg (Torino); 1987; 28(1):22-5. PubMed ID: 3805107
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activated clotting time (ACT) monitoring of intraoperative heparinization in peripheral vascular surgery.
    Mabry CD; Thompson BW; Read RC
    Am J Surg; 1979 Dec; 138(6):894-900. PubMed ID: 507308
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anticoagulation Obtained below the Arterial Clamp Using a Single Fixed Bolus of Heparin in Vascular Surgery: A Pilot Study.
    Roy M; Todorov A; Ruel M; Elkouri S; Hardy JF
    Ann Vasc Surg; 2018 Jul; 50():242-248. PubMed ID: 29481926
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of heparin concentration and activated clotting time monitoring on blood conservation. A prospective, randomized evaluation in patients undergoing cardiac operation.
    Despotis GJ; Joist JH; Hogue CW; Alsoufiev A; Kater K; Goodnough LT; Santoro SA; Spitznagel E; Rosenblum M; Lappas DG
    J Thorac Cardiovasc Surg; 1995 Jul; 110(1):46-54. PubMed ID: 7609568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the activated clotting time and activated partial thromboplastin time for the monitoring of heparin in adult extracorporeal membrane oxygenation patients.
    Atallah S; Liebl M; Fitousis K; Bostan F; Masud F
    Perfusion; 2014 Sep; 29(5):456-61. PubMed ID: 24570077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of a rapid monitoring system to study heparin pharmacokinetics and pharmacodynamics.
    Cipolle RJ; Uden DL; Gruber SA; Jossart GH; Taylor CA; Erdmann GR; Canafax DM
    Pharmacotherapy; 1990; 10(6):367-72. PubMed ID: 2287554
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systemic heparinization during peripheral vascular surgery: thromboelastographic, activated coagulation time, and heparin titration monitoring.
    Martin P; Greenstein D; Gupta NK; Walker DR; Kester RC
    J Cardiothorac Vasc Anesth; 1994 Apr; 8(2):150-2. PubMed ID: 8204807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activated coagulation time in monitoring heparinized dogs.
    Green RA
    Am J Vet Res; 1980 Nov; 41(11):1793-7. PubMed ID: 7212408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of the activated clotting time in heparin administration and neutralization for cardiopulmonary bypass.
    Esposito RA; Culliford AT; Colvin SB; Thomas SJ; Lackner H; Spencer FC
    J Thorac Cardiovasc Surg; 1983 Feb; 85(2):174-85. PubMed ID: 6823136
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monitoring of blood coagulation in open heart surgery. I. Effects of conventional dosages of heparin and protamine.
    Dercksen SJ; Linssen GH
    Acta Anaesthesiol Belg; 1980; 31(2):113-9. PubMed ID: 7468137
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo and in vitro evaluation of the heparin management test versus the activated coagulation time for monitoring anticoagulation level in aprotinin-treated patients during cardiac surgery.
    Kim YS; Murkin JM; Adams SJ
    Heart Surg Forum; 2004; 7(6):E599-604. PubMed ID: 15769695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [How much dosage of heparin do you administer? The relationship between heparin dosage and activated coagulation time (ACT) value during cardiovascular surgery: a multi center investigations].
    Shibasaki M; Nakajima Y; Kojima A; Kitagawa H; Tanimoto K; Mizobe T
    Masui; 2010 Apr; 59(4):535-9. PubMed ID: 20420155
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heparin activity monitoring during vascular surgery.
    Jacobsen W; Brauer F; Smith LL
    Am J Surg; 1978 Jul; 136(1):141-4. PubMed ID: 677381
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of MDCO-2010, a serine protease inhibitor, on activated clotting time in blood obtained from volunteers and cardiac surgical patients.
    Kim H; Szlam F; Tanaka KA; van de Locht A; Ogawa S; Levy JH
    Anesth Analg; 2012 Aug; 115(2):244-52. PubMed ID: 22584552
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The relationship between heparin level and activated clotting time in the adult cardiac surgery population.
    Fitzgerald DJ; Patel A; Body SC; Garvin S
    Perfusion; 2009 Mar; 24(2):93-6. PubMed ID: 19654150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heparin dose for accurate anticoagulation in cardiac surgery.
    Doty DB; Knott HW; Hoyt JL; Koepke JA
    J Cardiovasc Surg (Torino); 1979; 20(6):597-604. PubMed ID: 511928
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monitoring of blood coagulation in open heart surgery. II. Use of individualized dosages of heparin and protamine controlled by activated coagulation times.
    Dercksen SJ; Linssen GH
    Acta Anaesthesiol Belg; 1980; 31(2):121-8. PubMed ID: 7468138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.